These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28532674)

  • 1. Cytokine expression levels in ALS: A potential link between inflammation and BMAA-triggered protein misfolding.
    Michaelson N; Facciponte D; Bradley W; Stommel E
    Cytokine Growth Factor Rev; 2017 Oct; 37():81-88. PubMed ID: 28532674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
    Banack SA; Caller TA; Stommel EW
    Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
    Banack SA; Metcalf JS; Bradley WG; Cox PA
    Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer's disease features in cortical neurons.
    Silva DF; Candeias E; Esteves AR; Magalhães JD; Ferreira IL; Nunes-Costa D; Rego AC; Empadinhas N; Cardoso SM
    J Neuroinflammation; 2020 Nov; 17(1):332. PubMed ID: 33153477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's Highlight: Embryonic Exposure to the Environmental Neurotoxin BMAA Negatively Impacts Early Neuronal Development and Progression of Neurodegeneration in the Sod1-G93R Zebrafish Model of Amyotrophic Lateral Sclerosis.
    Powers S; Kwok S; Lovejoy E; Lavin T; Sher RB
    Toxicol Sci; 2017 May; 157(1):129-140. PubMed ID: 28123103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
    Liu X; Rush T; Zapata J; Lobner D
    Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model.
    Cai HY; Tian KW; Zhang YY; Jiang H; Han S
    Aging (Albany NY); 2018 Nov; 10(11):3507-3527. PubMed ID: 30476904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric and neurochemical alterations found in l-BMAA treated rats.
    de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Martínez A; Arahuetes RM
    Environ Toxicol Pharmacol; 2015 May; 39(3):1232-45. PubMed ID: 26002186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
    Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.
    Field NC; Caller TA; Stommel EW
    Med Hypotheses; 2011 Oct; 77(4):565-7. PubMed ID: 21745715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
    Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
    Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic BMAA exposure combined with TDP-43 mutation elicits motor neuron dysfunction phenotypes in mice.
    Arnold FJ; Burns M; Chiu Y; Carvalho J; Nguyen AD; Ralph PC; La Spada AR; Bennett CL
    Neurobiol Aging; 2023 Jun; 126():44-57. PubMed ID: 36931113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD.
    Field NC; Metcalf JS; Caller TA; Banack SA; Cox PA; Stommel EW
    Toxicon; 2013 Aug; 70():179-83. PubMed ID: 23660330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
    Stommel EW; Field NC; Caller TA
    Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations.
    Okle O; Stemmer K; Deschl U; Dietrich DR
    Toxicol Sci; 2013 Jan; 131(1):217-24. PubMed ID: 23047912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.
    Caller TA; Field NC; Chipman JW; Shi X; Harris BT; Stommel EW
    Amyotroph Lateral Scler; 2012 Jan; 13(1):25-32. PubMed ID: 22214351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to BMAA mirrors molecular processes linked to neurodegenerative disease.
    Beri J; Nash T; Martin RM; Bereman MS
    Proteomics; 2017 Sep; 17(17-18):. PubMed ID: 28837265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.